Biotechnology Assets SA
MAD:BST
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biotechnology Assets SA
MAD:BST
|
ES |
|
P
|
Persimmon PLC
XMUN:OHP
|
UK |
|
A
|
Alpha Lithium Corp
OTC:ALLIF
|
CA |
|
Arteris Inc
NASDAQ:AIP
|
US |
|
Biomerieux SA
OTC:BMXMF
|
FR |
|
Airbnb Inc
NASDAQ:ABNB
|
US |
|
Clean Science and Technology Ltd
NSE:CLEAN
|
IN |
|
P
|
Principal Financial Group Inc
SWB:PG4
|
US |
|
Datatec Ltd
F:DTT
|
ZA |
|
E
|
Enel SpA
XMUN:ENL
|
IT |
|
C
|
Consolidated Edison Inc
SWB:EDC
|
US |
|
A
|
Amerco
F:AUK
|
US |
|
A
|
Asics Corp
XMUN:ASI1
|
JP |
|
Plazza AG
F:2PZ
|
CH |
|
G
|
Green Plains Inc
F:G3V
|
US |
|
C
|
Cu Tech Corp
KOSDAQ:376290
|
KR |
|
De.mem Ltd
ASX:DEM
|
AU |
Bankruptcy Probability
Biotechnology Assets SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Biotechnology Assets SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ES |
|
Biotechnology Assets SA
MAD:BST
|
14.5m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
459.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
240.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
187.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
141.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
87.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
55.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Biotechnology Assets SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Biotechnology Assets SA has total debt of 1m EUR. This includes both short-term (0 EUR) and long-term (1m EUR) debt.
You can find a full breakdown on its Balance Sheet.
